Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Sponsor

European Group for Research in Schizophrenia Stichting

The Netherlands Retstraat 13, 6658 DB, The Netherlands

About the sponsor

The sponsor’s clinical research is centered on schizophrenia, with particular attention to symptoms that affect daily functioning and long-term outcomes.

  • Cognitive impairment
  • Cognitive function
  • Adult schizophrenia

Its funded trial activity focuses on understanding treatment effects in adults living with schizophrenia, especially in relation to thinking, memory, and other cognitive domains.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

A study to evaluate the effect of xanomeline tartrate and trospium chloride on cognitive impairment in adults with schizophrenia.

Not yet recruiting
InvestigationalNo placebo
Countries:AustriaAustria
  • Participants:18–64 years
  • Substances:Trospium Chloride
  • Sponsor:European Group for Research in Schizophrenia Stichting

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.